Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections

被引：0

作者：

Philipp Schuetz

Marcel Wolbers

Mirjam Christ-Crain

Robert Thomann

Claudine Falconnier

Isabelle Widmer

Stefanie Neidert

Thomas Fricker

Claudine Blum

Ursula Schild

Nils G Morgenthaler

Ronald Schoenenberger

Christoph Henzen

Thomas Bregenzer

Claus Hoess

Martin Krause

Heiner C Bucher

Werner Zimmerli

Beat Mueller

机构：

[1] Diabetes and Clinical Nutrition,Department of Internal Medicine, Division of Endocrinology

[2] University Hospital Basel,Basel Institute for Clinical Epidemiology and Biostatistics

[3] University Hospital Basel,Oxford University Clinical Research Unit

[4] Wellcome Trust Major Overseas Program,Department of Internal Medicine

[5] Hospital for Tropical Diseases,Department of Internal Medicine

[6] Buergerspital Solothurn,Department of Internal Medicine

[7] Kantonsspital Liestal,Department of Internal Medicine

[8] Kantonsspital Lucerne,Department of Internal Medicine

[9] Kantonsspital Muensterlingen,undefined

[10] Kantonsspital Aarau,undefined

[11] Brahms AG,undefined

来源：

Critical Care | / 14卷

关键词：

Brier Score; Pneumonia Severity Index; Lower Respiratory Tract Infection; Clinical Risk Score; Receiver Operating Curf Curve;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Community-acquired pneumonia: pathophysiology and host factors with focus on possible new approaches to management of lower respiratory tract infections
Wunderink, RG
Waterer, GW
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (04) : 743 - +
[32] The aetiological agents in adult patients with community-acquired lower respiratory tract infections in Turkey
Koksal, I.
Ozlu, T.
Saral, O. Bayraktar
Aydin, K.
Caylan, R.
Oztuna, F.
Bulbul, Y.
Yilmaz, G.
Sucu, N.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S327 - S328
[33] New antibiotics for community-acquired lower respiratory tract infections: improved activity at a cost?
Ball, P
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (03) : 263 - 272
[34] CLINICAL-EVALUATION OF PEFLOXACIN IN COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTIONS
VANDERDONCKT, J
HELLEBRAND, A
CORDIER, R
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1988, 43 (01): : 82 - 91
[35] Prevalence and resistance pattern of Moraxella catarrhalis in community-acquired lower respiratory tract infections
Shaikh, Safia Bader Uddin
Ahmed, Zafar
Arsalan, Syed Ali
Shafiq, Sana
INFECTION AND DRUG RESISTANCE, 2015, 8 : 263 - 267
[36] Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Gardiner, Samantha J.
Gavranich, John B.
Chang, Anne B.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
[37] TREATMENT OF COMMUNITY-ACQUIRED LOWER RESPIRATORY-TRACT INFECTIONS WITH ORAL CEFUROXIME AXETIL
LIMSON, BM
GARVEZ, MD
CLINICAL THERAPEUTICS, 1990, 12 (05) : 436 - 439
[38] Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
Mulholland, Selamawit
Gavranich, John B.
Gillies, Malcolm B.
Chang, Anne B.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (09):
[39] Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children
Esposito, S
Blasi, F
Allegra, L
Principi, N
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (09) : 647 - 650
[40] Community-acquired lower respiratory tract infections - The concept of beta-lactaminase inhibitors
Jarlier, V
PRESSE MEDICALE, 1998, 27 : 17 - 18

← 1 2 3 4 5 →